125 related articles for article (PubMed ID: 28913154)
1. PET/CT imaging of the diapeutic alkylphosphocholine analog
Hall LT; Titz B; Robins HI; Bednarz BP; Perlman SB; Weichert JP; Kuo JS
Am J Nucl Med Mol Imaging; 2017; 7(4):157-166. PubMed ID: 28913154
[TBL] [Abstract][Full Text] [Related]
2. [
Hall LT; Titz B; Baidya N; van der Kolk AG; Robins HI; Otto M; Perlman SB; Weichert JP; Kuo JS
Mol Imaging Biol; 2020 Apr; 22(2):434-443. PubMed ID: 31183841
[TBL] [Abstract][Full Text] [Related]
3. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404.
Besemer AE; Titz B; Grudzinski JJ; Weichert JP; Kuo JS; Robins HI; Hall LT; Bednarz BP
Phys Med Biol; 2017 Jul; 62(15):6008-6025. PubMed ID: 28682793
[TBL] [Abstract][Full Text] [Related]
4. Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog.
Baiu DC; Marsh IR; Boruch AE; Shahi A; Bhattacharya S; Jeffery JJ; Zhao Q; Hall LT; Weichert JP; Bednarz BP; Otto M
J Nucl Med; 2018 Feb; 59(2):244-250. PubMed ID: 28747518
[TBL] [Abstract][Full Text] [Related]
5. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.
Weichert JP; Clark PA; Kandela IK; Vaccaro AM; Clarke W; Longino MA; Pinchuk AN; Farhoud M; Swanson KI; Floberg JM; Grudzinski J; Titz B; Traynor AM; Chen HE; Hall LT; Pazoles CJ; Pickhardt PJ; Kuo JS
Sci Transl Med; 2014 Jun; 6(240):240ra75. PubMed ID: 24920661
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.
Morris ZS; Weichert JP; Saker J; Armstrong EA; Besemer A; Bednarz B; Kimple RJ; Harari PM
Radiother Oncol; 2015 Sep; 116(3):504-9. PubMed ID: 26123834
[TBL] [Abstract][Full Text] [Related]
8. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.
Marino R; Baiu DC; Bhattacharya S; Titz B; Hebron E; Menapace BD; Singhal S; Eickhoff JC; Asimakopoulos F; Weichert JP; Otto M
Am J Cancer Res; 2015; 5(11):3422-35. PubMed ID: 26807322
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10.
Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
[No Abstract] [Full Text] [Related]
11. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
12. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.
Marsh IR; Li C; Grudzinski J; Jeffery J; Longhurst C; Adam DP; Hernandez R; Weichert JP; Harari PM; Bednarz BP
Cancer Biother Radiopharm; 2023 Sep; 38(7):458-467. PubMed ID: 37022739
[No Abstract] [Full Text] [Related]
13. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
14. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.
Grudzinski JJ; Titz B; Kozak K; Clarke W; Allen E; Trembath L; Stabin M; Marshall J; Cho SY; Wong TZ; Mortimer J; Weichert JP
PLoS One; 2014; 9(11):e111652. PubMed ID: 25402488
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623
[TBL] [Abstract][Full Text] [Related]
17. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.
Choi SJ; Kim JS; Kim JH; Oh SJ; Lee JG; Kim CJ; Ra YS; Yeo JS; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):653-9. PubMed ID: 15711980
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
